Emtricitabine/Tenofovir for post-exposure prophylaxis against HIV a review of clinical effectiveness and cost-effectiveness
The objective of this Rapid Response report is to evaluate the clinical and cost-effectiveness of TDF plus FTC, with or without integrase strand transfer inhibitors, as compared with other NRTI regimens with or without protease inhibitors boosted with ritonavir
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, March 17, 2017
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this Rapid Response report is to evaluate the clinical and cost-effectiveness of TDF plus FTC, with or without integrase strand transfer inhibitors, as compared with other NRTI regimens with or without protease inhibitors boosted with ritonavir |
|---|---|
| Physical Description: | 1 PDF file (22 pages) illustration |